Last updated on May 2018

An Adaptive Phase II/III Two-Part Double-Blind Randomized Placebo-controlled Dose-Finding Multi-center Study of the Safety and Efficacy of NaBen as an Add-on Therapy With Clozapine for Residual Symptoms of Refractory Schizophrenia in Adults


Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.